Phase II Study of Rituximab Given in Conjunction With Standard Chemotherapy in Primary Central Nervous System (CNS) Lymphoma.
Phase of Trial: Phase II
Latest Information Update: 18 May 2018
At a glance
- Drugs Rituximab (Primary) ; Cytarabine; Dexamethasone; Folinic acid; Methotrexate; Procarbazine; Vincristine
- Indications Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 23 May 2017 Status changed from suspended to discontinued.
- 08 Dec 2015 Primary endpoint has been met. (Complete response rate at the end of study treatment), as per results presented at the 57th Annual Meeting and Exposition of the American Society of Hematology.
- 08 Dec 2015 Results presented at the 57th Annual Meeting and Exposition of the American Society of Hematology